Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
Denmark · United Kingdom
File

United Kingdom: MVA-BN vaccine procurement

This dossier follows UK procurement of MVA-BN from Bavarian Nordic and documented deliveries.

Last updated : 1 key moments
Bavarian Nordic logo.
Identification logo; does not depict delivered doses. Public domain, PNG rendering. — Bavarian Nordic / Wikimedia Commons — domaine public (PD-textlogo), rendu PNG ; usage d’identification.

Where things stand

On 2 November 2026, Bavarian Nordic announced a four-year UK contract with no disclosed value.

Reported information

Bavarian Nordic announces four-year UK vaccine contract

Bavarian Nordic announced on 2 November 2026 a four-year contract with the United Kingdom, through the UK Health Security Agency, to supply its MVA-BN vaccine against mpox and smallpox.

Bavarian Nordic logo.
Identification logo; does not depict delivered doses. Public domain, PNG rendering. — Bavarian Nordic / Wikimedia Commons — domaine public (PD-textlogo), rendu PNG ; usage d’identification.

The Danish manufacturer plans scheduled deliveries over the contract term, with options allowing supplies to be adjusted. This procurement announcement does not document doses already delivered.

The UK health agency, quoted in the statement, describes the purchase as part of preparedness for infectious threats. Reuters reports that the contract value was not disclosed. No separate contract document was reviewed.

Sources 3